HOXD12 defines an age-related aggressive subtype of oligodendroglioma
Acta Neuropathologica · 2024
DOI: 10.1007/s00401-024-02802-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Nicholas Nuechterlein und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neuropathology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Dri…. Hauptthemen laut MEDLINE: Brain Neoplasms, Homeodomain Proteins, Oligodendroglioma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Science Foundation Graduate Research Fellowship Program, NINDS NIH HHS.
Abstract (Originalsprache)
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted has highly variable outcomes that are strongly influenced by patient age. The distribution of oligodendroglioma age is non-Gaussian and reportedly bimodal, which motivated our investigation of age-associated molecular alterations that may drive poorer outcomes. We found that elevated HOXD12 expression was associated with both older patient age and shorter survival in the TCGA (FDR < 0.01, FDR = 1e−5) and the CGGA ( p = 0.03, p < 1e−3). HOXD12 gene body hypermethylation was associated with older age, higher WHO grade, and shorter survival in the TCGA ( p < 1e−6, p < 0.001, p < 1e−3) and with older age and higher WHO grade in Capper et al. ( p < 0.002, p = 0.014). In the TCGA, HOXD12 gene body hypermethylation and elevated expression were independently prognostic of NOTCH1 and PIK3CA mutations, loss of 15q, MYC activation, and standard histopathological features. Single-nucleus RNA and ATAC sequencing data showed that HOXD12 activity was elevated in neoplastic tissue, particularly within cycling and OPC-like cells, and was associated with a stem-like phenotype. A pan-HOX DNA methylation analysis revealed an age and survival-associated HOX-high signature that was tightly associated with HOXD12 gene body methylation. Overall, HOXD12 expression and gene body hypermethylation were associated with an older, atypically aggressive subtype of oligodendroglioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuropathology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Building 10/3D17, Bethesda, MD, 20892, USA.
- School of Interdisciplinary Arts and Sciences, University of Washington, Bothell, WA, USA.
- Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA, USA.
- Division of Hematology and Oncology, Scripps Cancer Center, La Jolla, CA, USA.
ORCID-Profile: Patrick J Cimino
Förderung
- NCI NIH HHS
- National Science Foundation Graduate Research Fellowship Program
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Nuechterlein, N., Cimino, S., Shelbourn, A., Ha, V., Arora, S., Rajan, S., Shapiro, L. G., Holland, E. C., Aldape, K., McGranahan, T., Gilbert, M. R., & Cimino, P. J. (2024). HOXD12 defines an age-related aggressive subtype of oligodendroglioma. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02802-1
Vancouver
Nuechterlein N, Cimino S, Shelbourn A, Ha V, Arora S, Rajan S, et al. HOXD12 defines an age-related aggressive subtype of oligodendroglioma. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02802-1
BibTeX
@article{Nuechterlein2024,
author = {Nuechterlein, Nicholas and Cimino, Sadie and Shelbourn, Allison and Ha, Vinny and Arora, Sonali and Rajan, Sharika and Shapiro, Linda G and Holland, Eric C and Aldape, Kenneth and McGranahan, Tresa and Gilbert, Mark R and Cimino, Patrick J},
title = {HOXD12 defines an age-related aggressive subtype of oligodendroglioma},
journal = {Acta Neuropathologica},
year = {2024},
doi = {10.1007/s00401-024-02802-1}
}
EUVIMED